Evidence map›Paper›PMID 11741232›Full record

ArticleAAPS pharmSci2000

Human proton/oligopeptide transporter (POT) genes: identification of putative human genes using bioinformatics.

C W Botka, T W Wittig, R C Graul, C U Nielsen, K Higaka, G L Amidon, W Sadée

Abstract read
In one paragraph

Article in AAPS pharmSci, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Identification of SLC20A1 and SLC15A4 among other genes as potential risk factors for combined pituitary hormone deficiency.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Article
  6. Article
  7. The Concise Guide to PHARMACOLOGY 2013/14: transporters.British journal of pharmacology · 2013
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology.Pflugers Archiv : European journal of physiology · 2004
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

C W BotkaDepartment of Biopharmaceutical Sciences, University of California San Francisco, San Francisco CA 94143-0446, USA.
T W Wittig
R C Graul
C U Nielsen
K Higaka
G L Amidon
W Sadée
University of California, San Francisco · USUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proton-dependent oligopeptide transporters (POT) gene family currently consists of approximately 70 cloned cDNAs derived from diverse organisms. In mammals, two genes encoding peptide transporters, PepT1 and PepT2 have been cloned in several species including humans, in addition to a rat histidine/peptide transporter (rPHT1). Because the Candida elegans genome contains five putative POT genes, we searched the available protein and nucleic acid databases for additional mammalian/human POT genes, using iterative BLAST runs and the human expressed sequence tags (EST) database. The apparent human orthologue of rPHT1 (expression largely confined to rat brain and retina) was represented by numerous ESTs originating from many tissues. Assembly of these ESTs resulted in a contiguous sequence covering approximately 95% of the suspected coding region. The contig sequences and analyses revealed the presence of several possible splice variants of hPHT1. A second closely related human EST-contig displayed high identity to a recently cloned mouse cDNA encoding cyclic adenosine monophosphate (cAMP)-inducible 1 protein (gi:4580995). This contig served to identify a PAC clone containing deduced exons and introns of the likely human orthologue (termed hPHT2). Northern analyses with EST clones indicated that hPHT1 is primarily expressed in skeletal muscle and spleen, whereas hPHT2 is found in spleen, placenta, lung, leukocytes, and heart. These results suggest considerable complexity of the human POT gene family, with relevance to the absorption and distribution of cephalosporins and other peptoid drugs.

Indexed as

Membrane Transport ProteinsNerve Tissue ProteinsBlotting, NorthernCarrier ProteinsContig MappingDatabases, ProteinDipeptidesExpressed Sequence TagsHistidineHumansOrgan SpecificityPeptoidsProtein IsoformsReverse Transcriptase Polymerase Chain ReactionSoftwareCarrier ProteinsDipeptidesHistidineMembrane Transport ProteinsNerve Tissue ProteinsPeptoidsProtein IsoformsSLC15A3 protein, humanSLC15A4 protein, humanSlc15a4 protein, rat

Identifiers

PMID11741232
PMCPMC2751030
OpenAlexW2042120925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.